Logo image of PHN.MI

PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis

BIT:PHN - Euronext Milan - IT0005274094 - Common Stock - Currency: EUR

46.25  -1.6 (-3.34%)

Fundamental Rating

8

Taking everything into account, PHN scores 8 out of 10 in our fundamental rating. PHN was compared to 13 industry peers in the Personal Care Products industry. PHN gets an excellent profitability rating and is at the same time showing great financial health properties. PHN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make PHN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

PHN had positive earnings in the past year.
PHN had a positive operating cash flow in the past year.
Each year in the past 5 years PHN has been profitable.
PHN had a positive operating cash flow in each of the past 5 years.
PHN.MI Yearly Net Income VS EBIT VS OCF VS FCFPHN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

PHN has a better Return On Assets (18.91%) than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 36.18%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Invested Capital of PHN (23.97%) is better than 100.00% of its industry peers.
PHN had an Average Return On Invested Capital over the past 3 years of 17.21%. This is significantly above the industry average of 11.95%.
The last Return On Invested Capital (23.97%) for PHN is above the 3 year average (17.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.91%
ROE 36.18%
ROIC 23.97%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
PHN.MI Yearly ROA, ROE, ROICPHN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

With a decent Profit Margin value of 13.77%, PHN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
PHN's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 22.67%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
PHN has a better Gross Margin (95.55%) than 100.00% of its industry peers.
PHN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.67%
PM (TTM) 13.77%
GM 95.55%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
PHN.MI Yearly Profit, Operating, Gross MarginsPHN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHN is creating value.
Compared to 1 year ago, PHN has about the same amount of shares outstanding.
PHN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHN has an improved debt to assets ratio.
PHN.MI Yearly Shares OutstandingPHN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
PHN.MI Yearly Total Debt VS Total AssetsPHN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 8.28 indicates that PHN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.28, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHN has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
PHN's Debt to FCF ratio of 1.16 is amongst the best of the industry. PHN outperforms 92.31% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that PHN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, PHN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Altman-Z 8.28
ROIC/WACC3.01
WACC7.97%
PHN.MI Yearly LT Debt VS Equity VS FCFPHN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.29 indicates that PHN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.29, PHN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
A Quick Ratio of 2.02 indicates that PHN has no problem at all paying its short term obligations.
PHN's Quick ratio of 2.02 is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 2.02
PHN.MI Yearly Current Assets VS Current LiabilitesPHN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.72%, which is quite impressive.
Measured over the past years, PHN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.63% on average per year.
PHN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.16%.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%

3.2 Future

Based on estimates for the next years, PHN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.90% on average per year.
The Revenue is expected to grow by 11.78% on average over the next years. This is quite good.
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PHN.MI Yearly Revenue VS EstimatesPHN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHN.MI Yearly EPS VS EstimatesPHN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.11 indicates a rather expensive valuation of PHN.
PHN's Price/Earnings ratio is rather cheap when compared to the industry. PHN is cheaper than 84.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHN to the average of the S&P500 Index (27.30), we can say PHN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.24, the valuation of PHN can be described as rather expensive.
PHN's Price/Forward Earnings is on the same level as the industry average.
PHN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.11
Fwd PE 18.24
PHN.MI Price Earnings VS Forward Price EarningsPHN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PHN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHN is cheaper than 61.54% of the companies in the same industry.
PHN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.64
EV/EBITDA 10.61
PHN.MI Per share dataPHN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.16
PEG (5Y)1.31
EPS Next 2Y15.44%
EPS Next 3Y12.9%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.17%, PHN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.55, PHN pays a bit more dividend than its industry peers.
PHN's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

35.05% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
The dividend of PHN is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP35.05%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
PHN.MI Yearly Income VS Free CF VS DividendPHN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M
PHN.MI Dividend Payout.PHN.MI Dividend Payout, showing the Payout Ratio.PHN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

PHARMANUTRA SPA

BIT:PHN (7/11/2025, 7:00:00 PM)

46.25

-1.6 (-3.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)09-07 2025-09-07
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap447.70M
Analysts82.86
Price Target83.64 (80.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP35.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-1.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE 19.11
Fwd PE 18.24
P/S 2.64
P/FCF 21.64
P/OCF 18.01
P/B 6.95
P/tB 10.95
EV/EBITDA 10.61
EPS(TTM)2.42
EY5.23%
EPS(NY)2.54
Fwd EY5.48%
FCF(TTM)2.14
FCFY4.62%
OCF(TTM)2.57
OCFY5.55%
SpS17.49
BVpS6.66
TBVpS4.22
PEG (NY)1.16
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 18.91%
ROE 36.18%
ROCE 41.7%
ROIC 23.97%
ROICexc 35.83%
ROICexgc 57.7%
OM 22.67%
PM (TTM) 13.77%
GM 95.55%
FCFM 12.22%
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score8
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Debt/EBITDA 0.46
Cap/Depr 106.2%
Cap/Sales 2.46%
Interest Coverage 250
Cash Conversion 58.76%
Profit Quality 88.74%
Current Ratio 2.29
Quick Ratio 2.02
Altman-Z 8.28
F-Score8
WACC7.97%
ROIC/WACC3.01
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y235.79%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y134.99%
OCF growth 3Y0.14%
OCF growth 5Y11.34%